221.1 Outcome comparison between LDLT and DDT in a cohort of 840 pediatric recipients
Dr. Joao Seda Neto, Brazil
221.2 Ultrasound of muscle is a feasible tool to assess sarcopenia in children
Dr. Christopher Chu, United States
221.3 Impact of everolimus treatment for graft fibrosis based on pathological findings after pediatric living donor liver transplantation
Dr. Takehisa Ueno, Japan
221.4 Extended antibiotic prophylaxis may protect from infectious complications following PTC
Dr. Federico Barooty, Switzerland
221.5 Biliary reconstruction for pediatric living donor liver transplantation: Roux-en-Y hepaticojejunostomy or duct-to-duct choledochocholedochostomy?
Dr. Yusuke Yanagi, Japan
221.6 Pediatric Liver Transplant at Long-Distance High-Volume Centers Confers Improved Graft Survival Compared to Local Low-Volume Transplant Centers